News

Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...
A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...
CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...
Sino-American biopharma Ascentage Pharma announced that its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575 ...
Shares in US biotech Ultragenyx Pharmaceutical (Nasdaq: RARE) and its UK-based partner Mereo BioPharma (Nasdaq: MREO) tumbled ...
US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...
At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...
Chinese cell therapy developer NK CellTech has raised nearly 100 million renminbi ($14 million) in an extended series A+++ ...
California-based Renasant Bio announced its launch to advance next-generation disease-modifying treatments for autosomal ...
Lewy body dementia (LBD) remains one of the most overlooked and complex neurodegenerative conditions, but momentum is ...
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending Eli Lilly’s Omvoh ...
BrainXell, a US biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, has announced ...